Source:PIB
Subject: Health, Governance and Regulation (Drugs and Pharmaceutical Regulation)|Target exams: UPSC
Key points for Prelims: Drugs Rules, 1945, Bulk drugs, Form 19-BC and Form 20-BC, Narcotic Drugs and Psychotropic Substances Act, 1985, Drugs Technical Advisory Board, Drugs Consultative Committee
Mains syllabus mapping
- General Studies Paper 2: Health sector: regulation of pharmaceuticals, drug licensing, and role of statutory bodies such as the DTAB and DCC
- General Studies Paper 3: Internal security and drug trafficking: NDPS Act, 1985 and control of narcotic substances; antimicrobial resistance as a public health challenge
Drugs and Cosmetics Rules, 1945 (proposed incorporation of Good Storage and Distribution Practices): quick facts
- Parent law
- Drugs and Cosmetics Act, 1940; the Rules of 1945 implement this Act
- Guidance source
- GSDP guidance developed by the Central Drugs Standard Control Organisation (CDSCO)
- Scope of GSDP
- Procurement, purchasing, storage, distribution, transportation, documentation and record-keeping
Key facts for one-day exams
- The proposed bulk drug licence application is Form 19-BC.
- The proposed bulk drug wholesale licence is Form 20-BC.
- Draft notification G.S.R. 987(E) is dated 2 November 2026.
- The Drugs Consultative Committee agreed to the proposal at its 67th meeting.
- The Drugs Technical Advisory Board agreed to the proposal at its 93rd meeting.
Bulk drug wholesale licensing: why in the news?
The Ministry of Health and Family Welfare has issued a draft notification proposing separate licensing for bulk drug wholesale, a move that tightens regulatory oversight of the pharmaceutical supply chain and addresses enforcement gaps related to antimicrobial resistance and controlled substances.
The Union Ministry of Health and Family Welfare has proposed a separate licensing framework for the wholesale sale of bulk drugs, distinct from the existing common licence for formulations and bulk drugs. The draft notification, G.S.R. 987(E) dated 2 November 2026, proposes amendments to the Drugs Rules, 1945, and introduces a new application form (Form 19-BC) and licence form (Form 20-BC) specifically for bulk drugs, which include active or inactive bulk substances. The proposal was agreed upon by the Drugs Consultative Committee in its 67th meeting on 17 November 2025 and by the Drugs Technical Advisory Board in its 93rd meeting on 16 February 2026.
Under the proposed framework, the licence will capture the categories of bulk drugs handled by wholesalers, including those covered under the Narcotic Drugs and Psychotropic Substances Act, 1985. The sale of bulk drugs will be carried out under the personal supervision of a competent person, strengthening accountability in distribution and handling. The ministry said the amendment aims to give better control over the wholesale sale of bulk drugs and strengthen enforcement related to antimicrobial resistance and the movement of NDPS drugs. Existing licensees will be given time to comply: the requirements will apply upon expiry of their current retention period or 12 months after the final publication of the amendment, whichever is later. Stakeholders may submit objections and suggestions within 30 days of the Gazette copies being made available to the public.
Key features and how it works
- The Rules classify drugs into schedules (for example Schedule H, H1 and X) and set rules for storage, sale, display and prescription of each schedule.
- GSDP requirements would cover procurement, purchasing, storage, distribution, transportation, documentation and record-keeping across the supply chain.PIB
- Incorporating GSDP into the Rules would make the guidelines legally binding and give Central and State drug-control authorities a basis for inspection and enforcement.
- The framework seeks to improve documentation, record-keeping and traceability, and to make manufacturers, importers, wholesalers, distributors and stockists accountable.PIB
Related Static GK and comparison
- CDSCO is responsible for drug approvals, clinical trials, drug standards, imported drug quality control and coordination of State Drug Control Organisations.cdsco.gov.in
- Drugs Controller General of India (DCGI): head of the CDSCO, responsible for approval of licences for specified drug categories such as blood and blood products, IV fluids, vaccines and sera, and for setting standards for manufacturing, sale, import and distribution of drugs.
- Drugs and Cosmetics Act, 1940: the parent law that regulates import, manufacture and distribution of drugs in India; originally called the Drug Act and passed in 1940 on the recommendations of the Chopra Committee; the Rules of 1945 were made under it.
- Schedule H1 (notified in 2013): covers third and fourth generation antibiotics, some psychotropic drugs and anti-TB drugs; a separate register must be kept for their supply.
- Schedule X lists addictive drugs such as narcotics and psychotropics that have medicinal uses and must be kept under lock and key. Schedule H regulations also apply.
Achievements
- The proposal would incorporate GSDP guidelines into the Drugs Rules, 1945, building on CDSCO guidance.PIB
- Clear coverage of the full supply chain, from manufacturer or importer to the patient, makes responsibility easier to assign at each stage.
- The proposed framework would promote documentation, record-keeping and traceability.PIB
Challenges
- Enforcement depends on State drug-control authorities, so uneven capacity across States may affect uniform implementation.
- India's drug-regulatory framework has been criticised for lax laws, exploitable loopholes and inadequate enforcement.
- Smaller wholesalers and stockists may find new documentation and storage requirements costly to meet.
Way forward
- Monitor outcomes through regular inspection data from Central and State drug-control authorities.
- Provide handholding and guidance to small distributors and stockists to meet the new storage and record-keeping norms.
- Converge GSDP enforcement with the existing schedule-based controls and the CDSCO's inspection network.
Connected to this news
Drugs and Cosmetics Rules, 1945 (proposed incorporation of Good Storage and Distribution Practices)
The Drugs and Cosmetics Rules, 1945 are the implementing rules of the Drugs and Cosmetics Act, 1940, and the Centre has proposed adding Good Storage and Distribution Practices (GSDP) to them so that supply-chain storage and distribution norms become legally binding.
Timeline
19 November 2026
Health Ministry proposed incorporating GSDP guidelines (covering storage, distribution and record-keeping of drugs) into the Drugs Rules, 1945, making them legally binding; stakeholders invited to send objections and suggestions.
Read the story19 November 2026This story
Draft notification G.S.R. 987(E) proposes separate licensing for bulk drug wholesale under the Drugs Rules, 1945, using new Forms 19-BC and 20-BC, with existing licensees given time to comply.
19 November 2026
Health Ministry published a draft amendment to the Drugs Rules, 1945, proposing continued Schedule M exemptions for medicinal gases, empty gelatin capsules and disinfectant fluids, based on a DTAB recommendation, open for public objections.
Read the story8 September 2026
Draft notification G.S.R. 791(E) proposed mandatory CCTV at retail premises selling Schedule H, H1 and X drugs; not yet in force as of September 2026.
2013
Schedule H1 notified.
1945
Drugs and Cosmetics Rules, 1945 made to implement the Act.
Bulk drug wholesale licensing: current and proposed
| Feature | Current | Proposed |
|---|---|---|
| Licence | Common with formulations | Separate bulk drug licence |
| Application | Common licensing arrangement | Form 19-BC |
| Licence form | Common licensing arrangement | Form 20-BC |
Key terms
- Bulk drug:
- A drug substance handled in bulk; the proposed framework covers active or inactive bulk substances.
- Formulation:
- A pharmaceutical product prepared in a dosage form for use, such as a tablet or capsule.
- Antimicrobial resistance:
- The ability of microorganisms to survive or grow despite exposure to medicines intended to treat them.
- Draft rules:
- Proposed rules published for consideration before their finalisation.
Bulk drug wholesale licensing: why it matters for exams
Exams: UPSC
Syllabus: Governance: Regulation and public policy; Science and Technology: Health and antimicrobial resistance
Common mistake: Examiners may present Form 20-BC as the application form and Form 19-BC as the licence; the proposal assigns these roles in the opposite order.
Mains practice questions
Question 1(GS-2 | 250 words | 15 marks)
Separate licensing for the wholesale of bulk drugs under the proposed amendment to the Drugs Rules, 1945 is a step towards tighter regulation of the pharmaceutical supply chain. Critically examine how such regulatory reform can address concerns over antimicrobial resistance and the diversion of NDPS drugs, and discuss the challenges in enforcing it.
Answer outline
- Introduction: Open by noting that the Health Ministry's draft amendment (G.S.R. 987(E)) proposes a separate licence for bulk drug wholesalers through Forms 19-BC and 20-BC, reflecting a shift from a common licence to targeted oversight.
- Body:
- Explain how a distinct licence creates accountability by linking each wholesaler to a licensed record and to the requirement of personal supervision by a competent person.
- Discuss the link to antimicrobial resistance: uncontrolled wholesale distribution of antibiotic bulk substances can encourage irrational use and resistance, and traceable licensing helps regulators monitor movement.
- Highlight the NDPS dimension: bringing NDPS-covered substances within the licensing category improves control over diversion into illicit channels.
- Discuss enforcement challenges: fragmented state regulatory capacity, inspection shortages, informal supply chains, and the need for digital traceability and inter-agency coordination.
- Note the transition design, where existing licensees get time to comply, and how this balances compliance with industry continuity.
- Conclusion: Conclude that separate licensing is a sound regulatory step, but its impact depends on robust inspection, digital traceability, and coordination between the Centre and states, with public consultation as an opportunity to refine it.
Question 2(GS-2 | 150 words | 10 marks)
Discuss the role of statutory advisory bodies such as the Drugs Consultative Committee and the Drugs Technical Advisory Board in the making of drug regulation in India, with reference to the proposed bulk drug wholesale licensing framework.
Answer outline
- Introduction: Open by noting that the bulk drug wholesale proposal was agreed upon by the Drugs Consultative Committee and the Drugs Technical Advisory Board before the draft notification was issued.
- Body:
- Describe the DCC and DTAB as expert advisory bodies that review proposed amendments to the Drugs Rules, 1945, ensuring technical and policy input before notification.
- Explain how their deliberation adds credibility and reduces the risk of poorly designed rules, with reference to the 2025 and 2026 meetings cited.
- Point out the role of the public consultation window of 30 days, which complements expert advice with stakeholder input.
- Conclusion: Conclude that advisory bodies strengthen evidence-based regulation, and that combining expert review with public consultation supports balanced drug policy.
Stuck? Get it in one tap
Bulk drugs are drug substances handled in bulk before or apart from finished formulations. The government has proposed a separate licence for their wholesale sale to improve oversight. Existing licensees would have a transition period after the rules are finalised.
- Governance: Regulation and public policy
- Science and Technology: Health and antimicrobial resistance
Related concepts: Bulk drug, Formulation, Antimicrobial resistance, Draft rules
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which ministry proposed the separate bulk drug wholesale licensing framework under the Drugs Rules, 1945?
Explanation: The Ministry of Health and Family Welfare proposed the amendments to the Drugs Rules, 1945. The other ministries are not the ministry that issued this proposal.
- Q2Hard
Consider the following statements about the proposed bulk drug wholesale licensing framework:
- 1. Form 20-BC is proposed as the application form.
- 2. The licence would capture categories of bulk drugs handled by wholesalers.
- 3. Bulk drug sales would be under the personal supervision of a competent person.
Which of the statements given above is/are correct?
Explanation: Statement 1 is incorrect: Form 19-BC is the proposed application, while Form 20-BC is the licence. Statements 2 and 3 correctly describe category recording and competent-person supervision.
- Q3Medium
How long after final publication is the proposed transition period threshold for existing bulk drug licensees?
Explanation: The proposed threshold is 12 months after final publication, not 6, 9 or 18 months. Existing licensees would comply at that point or when their current retention period expires, whichever is later.
- Q4Medium
What is the primary regulatory objective of the proposed separate bulk drug wholesale licence?
Explanation: The proposed separate licence is designed for focused oversight and accountability in bulk drug wholesale. A common licence is the existing arrangement, and controlled drugs would remain within the proposed category-based oversight.
Frequently asked questions
1. What is the proposed application form for bulk drug wholesale licensing?
Form 19-BC is the proposed application form; Form 20-BC is the proposed licence form.
2. When would existing bulk drug licensees need to comply with the proposed rules?
Compliance would be required on expiry of the current retention period or 12 months after final publication, whichever is later.
3. Who would supervise bulk drug sales under the proposed framework?
A competent person would personally supervise the sale of bulk drugs.
4. How long can stakeholders comment on the proposed bulk drug rules?
Objections and suggestions may be submitted within 30 days of Gazette copies containing the draft rules becoming available to the public.
All sources
Original19 November 2026 · Read story


